What is GANX's dilution risk score?

GANX has a latest available DilutionScore record of 58/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for GANX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for GANX?

DilutionWatch tracks 25 SEC filing types for GANX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect GANX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For GANX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for GANX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for GANX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

GANX Dilution Risk Score: 58/100 (HIGH)

Score Breakdown

📋 Offering Ability

💰 Cash Runway

📊 Float Risk

⚠️ Warrant Exposure

🔄 Convertible Debt

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 27%

🔄 Reverse Split model est. 40%

• 50-day avg $1.88 approaching $1 threshold

• 11 months cash with weak price

💰 Capital Raise model 15%

• Under 12 months cash (11mo)

📜 Warrant Exercise model 15%

• Warrant overhang: 12.1% of shares outstanding

🔔 Track GANX — Get forecast alerts →

Market Data

Market Cap$68.52M

Shares Outstanding43.64M

Float41.65M

Cash$15.10M

Debt$343.7K

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	58/100	DilutionWatch score record
Shares Outstanding	43.64M	Verified float table or market cache
Public Float	41.65M	Verified float table or market cache
Market Cap	$68.52M	Market data cache
Cash Runway	11.1 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	5.27M	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)

43 institutional holders · 9.05M shares

#1 MARSHALL WACE, LLP 1.77M shares

#2 Potomac Capital Management, Inc. 1.01M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 799.8K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.06M

Days to Cover5.9

% of Float7.3%

FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-11

Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GANX Dilution Snapshot

Gain Therapeutics, Inc. (GANX) has a DilutionScore of 58/100, rated High dilution risk. Score date: October 13, 2026.

Stored outstanding warrants: 5.3M.
Recent SEC activity tracked for GANX: xbrl on 2026-08-11.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GANX's DilutionScore is currently 58/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 52/100 (High risk).

Period	Score	Risk Level	Duration
Oct 01 – Oct 13, 2026	58/100	HIGH	13 days
Aug 22 – Sep 30, 2026	52/100	HIGH	40 days
Aug 14 – Aug 21, 2026	48/100	MEDIUM	7 days
Jul 16 – Aug 13, 2026	45/100	MEDIUM	29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GANX shares outstanding have decreased 0.0% from 42.65M (May 2026) to 42.65M (May 2026). Each increase represents potential dilution to existing shareholders.

Date	Shares Outstanding	Public Float	Change
May 13, 2026	42.65M	41.65M	▲ 0.98%
May 09, 2026	42.65M	41.24M	▲ 0.02%
May 03, 2026	42.65M	41.23M	▲ 0.81%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GANX Dilution Risk in Real-Time

DilutionWatch monitors SEC filings 24/7 and alerts you the moment GANX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.

Start Tracking GANX — Free

Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously